Previous Page  7 / 16 Next Page
Information
Show Menu
Previous Page 7 / 16 Next Page
Page Background

Page 33

Notes:

Volume 5

Journal of Current Research: Cardiology

Heart Congress 2018

November 21-22, 2018

2

nd

Global Heart Congress

November 21-22, 2018 Osaka, Japan

Different techniques of cardiac leads extraction: 17-years single center experience

A Piro, C Lavalle, A Ciccaglioni, M Alfarano, M C Gatto, M V Mariani, M Straito, G M Schiaffini, A Ceccacci, G Giunta, M Mancone and F Fedele

Sapienza University of Rome, Italy

Background & Aim:

Cardiovascular Implantable Electronic Devices (CIEDs) have become an important therapeutic modality

of cardiovascular care. The increasing rate of CIEDs implantation determines an increasing rate of CIEDs related complications,

especially including devices and leads infections that represent the strongest indication for the complete system removal. Therefore,

it is clear the importance of providing safe and efficient Transvenous Lead Extraction (TLE) techniques. TLE techniques used

until now, although very effective, are not without risk especially in elderly patients with significant comorbidities. The aim of our

study is to evaluate the safety and the efficacy related to lead extraction of CIEDs with all currently available techniques (simple

manual traction, mechanical sheaths and high-frequency excimer laser). We explore the indications, complications, and success rates

involved in the removal of CIEDs leads in our center, over 17 years.

Method:

We enrolled 447 consecutive patients (mean age 72,8 years, 74% male and 26% female) undergoing TLE between

December 2001 and February 2018. In total 955 leads were extracted, 353 of which were atrial, 278 ventricular, 213 ICD (Implantable

Cardioverter Defibrillator) leads and 111 were left leads for coronary sinus. The indications for TLE were pocket infection (44%),

sepsis (31%), lead failure (16%) and others causes (9%). Lead implant mean duration was 54 months. 87 leads (9%) were extracted

using Lead-Locking-Device (LLD), 497 (52%) using high-frequency excimer laser, 235 (25%) using mechanical sheaths and 136

(14%) using simple manual traction. For 15 leads (1.5%) TLE needed femoral transvenous approach. A complete transvenous lead

extraction without complications was considered successful.

Result:

Overall 879 leads (92%) were successfully and completed extracted, 65 leads were partially extracted with no other

complications and 11 leads (1%) were not extracted. There were major complications in 14 patients (3.13%) such us pericardial

effusion, cardiac tamponade, bradycardia, superior cava vein rupture, sub-clavian vein thrombosis, jugular thrombosis and hematoma.

All-cause mortality related to TLE procedure was 0.89% (n=4) at 1 year of follow-up. The all-cause mortality at two years of follow-

up was 9.43% (n=45).

Conclusion:

According to our experience, transvenous lead extraction can be safely and successfully performed in the majority of

patients regardless of the technique used (LLD, high-frequency excimer laser and mechanical sheaths). However, the mortality of

patients extracted for systemic infection remains slightly high at two years follow-up.

Agostino.piro@uniroma1.it

Curr Res Cardiol 2018, Volume 5

DOI: 10.4172/2368-0512-C1-003